Cargando…

Cardio protective effect of nicorandil in reperfusion injury among patients undergoing primary percutaneous coronary intervention

OBJECTIVES: To evaluate the effect of nicorandil in prevention of reperfusion injury during primary percutaneous coronary intervention by thrombolysis in myocardial infarction flow grade scoring. METHODS: A total of 140 patients from Rawalpindi Institute of Cardiology were enrolled in this study con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ilyas, Maria, Noor, Mudassar, Khan, Hamid Sharif, Haroon, Sauleha, Farhat, Kulsoom, Ali, Shabana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Professional Medical Publications 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842976/ https://www.ncbi.nlm.nih.gov/pubmed/36694786 http://dx.doi.org/10.12669/pjms.39.1.6034

Ejemplares similares

Cardioprotective Effects of Nicorandil on Coronary Heart Disease Patients Undergoing Elective Percutaneous Coronary Intervention
por: Pang, Zhihua, et al.
Publicado: (2017)

Meta-analysis of Nicorandil effectiveness on myocardial protection after percutaneous coronary intervention
por: Zhao, Xiao-Tao, et al.
Publicado: (2019)

Impact of intracoronary nicorandil before stent deployment in patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Xu, Xingli, et al.
Publicado: (2020)

Effect of nicorandil administration on cardiac burden and cardio-ankle vascular index after coronary intervention
por: Sato, Shuji, et al.
Publicado: (2020)

Granisetron versus Ondansetron: Comparison of 5HT(3) antagonists in preventing spinal anaesthesia induced hemodynamic instability in obstetric patients
por: Wahid, Maheen, et al.
Publicado: (2022)

Nicorandil in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
por: Wu, Muli, et al.
Publicado: (2013)

Renoprotective effect of nicorandil in patients undergoing percutaneous coronary intervention: a meta-analysis of 4 randomized controlled trials
por: Wang, Xiaobing, et al.
Publicado: (2018)

Efficacy and safety of nicorandil on perioperative myocardial injury in patients undergoing elective percutaneous coronary intervention: results of the PENMIPCI trial
por: Ye, Ziliang, et al.
Publicado: (2018)

Intracoronary application of nicorandil regulates the inflammatory response induced by percutaneous coronary intervention
por: Hu, Keqing, et al.
Publicado: (2020)

Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention
por: Campo, Gianluca, et al.
Publicado: (2017)

The effect of Dapagliflozin on renal functions in hospitalized patients with Acute Heart Failure
por: Gilani, Syedah Fauzia Fatima, et al.
Publicado: (2023)

Cardioprotective effects of single oral dose of nicorandil before selective percutaneous coronary intervention
por: Yang, Jing, et al.
Publicado: (2015)

Assessment of the Efficacy and Safety of Early Intracoronary Nicorandil Administration in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Gupta, Himanshu, et al.
Publicado: (2022)

Myocardial protective effect of intracoronary administration of nicorandil and alprostadil via targeted perfusion microcatheter in patients undergoing elective percutaneous coronary intervention: A randomized controlled trial
por: Zhang, Weifeng, et al.
Publicado: (2021)

Protective effect of ischaemic postconditioning combined with nicorandil on myocardial ischaemia‒reperfusion injury in diabetic rats
por: Xia, Zongyi, et al.
Publicado: (2022)

Effects of nicorandil infusion on ECG parameters in patients with unstable angina pectoris and percutaneous coronary intervention
por: Wang, Weiding, et al.
Publicado: (2019)

Effects of nicorandil on systemic inflammation and oxidative stress induced by percutaneous coronary intervention in patients with coronary heart disease
por: Zong, Yulong, et al.
Publicado: (2021)

Effects of Nicorandil Administration on Infarct Size in Patients With ST‐Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The CHANGE Trial
por: Qian, Geng, et al.
Publicado: (2022)

Intracoronary administration of nicorandil during primary percutaneous coronary intervention: Impact on restoration of regional myocardial perfusion in reperfused myocardium during the subacute phase of myocardial infarction
por: Takabatake, Wataru, et al.
Publicado: (2015)

Effect of nicorandil administration on myocardial microcirculation during primary percutaneous coronary intervention in patients with acute myocardial infarction
por: Feng, Chunguang, et al.
Publicado: (2018)

Intracoronary administration of nicorandil-induced cardiac arrest during primary percutaneous coronary intervention: A case report
por: Wei, Shu-Jian, et al.
Publicado: (2019)

Surveillance of Cardio Vascular Risk Factors Among Patients Undergoing Coronary Artery Bypass Surgery
por: Furnaz, Shumaila, et al.
Publicado: (2015)

The Role of Nicorandil in the Management of Chronic Coronary Syndromes in the Gulf Region
por: Cheng, Kevin, et al.
Publicado: (2020)

Protective effect of nicorandil on myocardial injury following percutaneous coronary intervention in older patients with stable coronary artery disease: Secondary analysis of a randomized, controlled trial (RINC)
por: Kawakita, Norifumi, et al.
Publicado: (2018)

Effects of mitochondrial ATP-sensitive potassium channel activation (nicorandil) in patients with angina pectoris undergoing elective percutaneous coronary interventions: A meta-analysis of randomized controlled trials
por: Zhu, Houyong, et al.
Publicado: (2019)

Effects of nicorandil on myocardial infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: study design and protocol for the randomized controlled trial
por: JIANG, Xiao-Si, et al.
Publicado: (2020)

Sustained nicorandil administration reduces the infarct size in ST-segment elevation myocardial infarction patients with primary percutaneous coronary intervention
por: Wang, Shanjie, et al.
Publicado: (2019)

Effect of nicorandil treatment adjunctive to percutaneous coronary intervention in patients with acute myocardial infarction: a systematic review and meta-analysis
por: Zhou, Jin, et al.
Publicado: (2020)

Intracoronary nicorandil induced hyperemia for physiological assessments in the coronary artery lesions
por: Yang, Xia, et al.
Publicado: (2022)

Combined Systemic Intake of K-ATP Opener (Nicorandil) and Mesenchymal Stem Cells Preconditioned With Nicorandil Alleviates Pancreatic Insufficiency in a Model of Bilateral Renal Ischemia/Reperfusion Injury
por: ShamsEldeen, Asmaa Mohammed, et al.
Publicado: (2022)

Nicorandil induced penile ulceration
por: Kinney, Michael, et al.
Publicado: (2010)

Nicorandil induced ophthalmoplegic migraine
por: Cadman-Davies, Morgan G, et al.
Publicado: (2012)

Vasodilator Therapy: Nitrates and Nicorandil
por: Tarkin, Jason M., et al.
Publicado: (2016)

The clinical effect of nicorandil on perioperative myocardial protection in patients undergoing elective PCI: A Systematic Review and Meta-Analysis
por: Ye, Ziliang, et al.
Publicado: (2017)

Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction
por: Qi, Qi, et al.
Publicado: (2018)

Efficacy and Safety of Nicorandil in Preventing Contrast-Induced Nephropathy after Elective Percutaneous Coronary Intervention: A Pooled Analysis of 1229 Patients
por: Yi, Bin, et al.
Publicado: (2020)

Impact of administration of nicorandil prior to percutaneous coronary intervention in treatment of acute myocardial infarction: A protocol for systematic review and meta-analysis
por: Li, Weijun, et al.
Publicado: (2021)

Preventive Effect of Pretreatment with Intravenous Nicorandil on Contrast-Induced Nephropathy in Patients with Renal Dysfunction Undergoing Coronary Angiography (PRINCIPLE Study)
por: Ko, Young-Guk, et al.
Publicado: (2013)

Myocardial Protective Effects of Nicorandil on Rats with Type 2 Diabetic Cardiomyopathy
por: Zhang, Meng, et al.
Publicado: (2018)

Protective Effect of Nicorandil on Cardiac Microvascular Injury: Role of Mitochondrial Integrity
por: Jiang, Xiaosi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v5in9qge78h6m0l59u0l9not56